CD8A and tuberculosis: Furthermore, an in vitro study reported that indomethacin, a non-steroidal anti-inflammatory drug that inhibits COX1/2 and regulates uncontrolled proliferation of CD4+, CD8+, and regulatory T cells contributing to TB pathogenesis (125) (Table 1).